Showing results (101-110 of 146) with videos related to
Sort By:
Pageof 15
Echo Research and Practice|August 16, 2019
Application of the Boston Technical Performance Score to intraoperative echocardiographyHannah R Bellsham-Revell, Antigoni Deri, Silvia Caroli, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 25, 2010
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trialSusan R Kahn, Ian Shrier, Stan Shapiro, et al.Plos One|February 2, 2016
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A SubunitRobert A Volkmann, Christopher M Fanger, David R Anderson, et al.Bioorganic & Medicinal Chemistry Letters|June 16, 2007
Novel tetrahydro-beta-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)John I Trujillo, Marvin J Meyers, David R Anderson, et al.Journal of Thrombosis and Haemostasis : JTH|January 29, 2023
The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolismLucia Caiano, Michael J Kovacs, Alejandro Lazo-Langner, et al.Journal of Occupational and Environmental Medicine|January 24, 2014
The predictive validity of the HERO Scorecard in determining future health care cost and risk trendsRon Z Goetzel, Rachel Mosher Henke, Richele Benevent, et al.Bioorganic & Medicinal Chemistry Letters|July 12, 2011
Discovery of indazoles as inhibitors of Tpl2 kinaseYonghan Hu, Derek Cole, Rajiah Aldrin Denny, et al.BMJ (Clinical Research Ed.)|June 10, 2021
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J Kovacs, Philip S Wells, David R Anderson, et al.Thrombosis Research|October 6, 2023
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort studyYan Xu, Faizan Khan, Michael J Kovacs, et al.Journal of Medicinal Chemistry|October 27, 2012
Covalent inhibitors of interleukin-2 inducible T cell kinase (itk) with nanomolar potency in a whole-blood assayChristoph W Zapf, Brian S Gerstenberger, Li Xing, et al.Pageof 15